Anusha Thumma | Pharmaceutical Sciences| Best Researcher Award

Dr. Anusha Thumma | Pharmaceutical Sciences | Best Researcher Award

scientist at nova southeastern university, United States

Dr. Anusha Thumma holds a Ph.D. in Pharmaceutical Sciences and specializes in drug formulation, abuse-deterrent technologies, inhalation products, and vaccine adjuvants. With expertise in HPLC, qPCR, ELISA, DSC, and flow cytometry, she ensures regulatory compliance with FDA, ICH, GMP, and GLP standards. She has worked as an Associate Scientist at Lupin Pharmaceuticals, an R&D Scientist at US Pharma LTD, and an Associate Professor at Radex Regulatory Affairs. Her research includes mRNA vaccine lipid nanoparticles and opioid abuse-deterrent formulations. She excels in project management, data analysis (Minitab), and cross-functional collaboration.

Publication Profile

Orcid

๐ŸŽ“ Education

Dr. Anusha Thumma holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Nova Southeastern University, USA (2023), where her dissertation focused on Abuse-Deterrent Composites: A Multi-Angle Approach. She earned her Master of Pharmacy (MPharm) from Osmania University, India (2013), specializing in Formulation and Characterization of Imiquimod Multiple Emulsion as a Novel Vaccine Delivery System. Her academic journey began with a Bachelor of Pharmacy (BPharm) from Kakatiya University, India (2011). With a strong foundation in pharmaceutical sciences, her research contributions span drug formulation, regulatory affairs, and vaccine development. ๐Ÿ’Š๐Ÿ”ฌ

๐Ÿ† Academic Excellence & Professional Achievements

Dr. Anusha Thumma has been recognized with multiple prestigious scholarships and grants for her outstanding academic and research contributions. She received a fully funded PhD scholarship and a PhD Scholar Stipend from Nova Southeastern University, USA, along with the President’s Faculty Research and Development Grant and HPD Research Grant for her research excellence. She also secured fully funded scholarships for her Masterโ€™s (Osmania University) and Bachelorโ€™s (Kakatiya University) degrees in India. Additionally, she holds a Professional Diploma in Regulatory Affairs (USA), is a Registered Pharmacist (India), and has attended webinars on drug discovery. ๐Ÿ“œ๐ŸŽ“๐Ÿ’Š

 

๐Ÿ”ฌ Research Focus Areas

Dr. Anusha Thummaโ€™s research primarily focuses on environmental remediation ๐ŸŒฑ, pharmaceutical sciences ๐Ÿ’Š, and drug abuse potential ๐Ÿงช. She has made significant contributions to water purification by exploring biochar-based adsorption for removing heavy metals (cadmium, zinc, arsenic) and dyes from polluted water. Her expertise extends to pharmaceutical formulations, particularly in abuse-deterrent drug delivery systems. Additionally, she investigates the toxicity and abuse potential of fentanyl analogues. Her interdisciplinary work integrates biopolymer-based cryostructures, advancing biomedical and pharmaceutical applications. Through her research, she aims to enhance sustainable environmental solutions and safer pharmaceutical formulations. ๐ŸŒ๐Ÿ”ฌ๐Ÿ’ง

Publication Top Notes

  • Adsorptive removal of arsenic from drinking water using KOH-modified sewage sludge-derived biochar
  • Exploring the efficiency of sodium alginate beads and Cedrus deodara sawdust for adsorptive removal of crystal violet dye

  • Advances in cryostructures and their applications in biomedical and pharmaceutical products

  • Abuse potential of fentanyl and fentanyl analogues

  • Removal of cadmium and zinc from water using sewage sludge-derived biochar

  • Potential of easily available low-cost raw cotton for the elimination of methylene blue dye from polluted water

Chang Wang | Pharmacokinetic | Best Researcher Award

Mr. Chang Wang | Pharmacokinetic | Best Researcher Award

Mr. Chang Wang, The Second Hospital & Clinical Medical School, Lanzhou University, China

Mr. Chang Wang is a dedicated Pharmacist In-Charge at Lanzhou University’s Second Hospital. He holds a Doctor of Medicine candidacy in Traditional Chinese Pharmacy from Gansu University of Chinese Medicine. His expertise spans therapeutic drug monitoring and clinical pharmacology, with significant contributions in drug interactions and high-altitude pharmacology. Mr. Wang has published widely, including in the Journal of Chromatography B and Journal of Mass Spectrometry. He has received the First Prize for Military Scientific and Technological Progress and is an active member of several professional societies, including the International Association of Therapeutic Drug Monitoring. ๐Ÿ’Š๐Ÿ“š

 

Publication Profile

Scopus

Educational Background ๐ŸŽ“

Mr. Chang Wang is currently pursuing a Doctor of Medicine in Traditional Chinese Pharmacy at Gansu University of Chinese Medicine (2024-present). He earned his Master of Pharmacy from Lanzhou University, School of Pharmacy (2012-2015), where he deepened his expertise in pharmaceutical sciences. Prior to that, he completed his Bachelor of Science in Pharmacy at Lanzhou University, School of Pharmacy (2008-2012). Mr. Wang’s solid educational foundation has enabled him to advance his career as a clinical pharmacist and contribute significantly to the field of therapeutic drug monitoring and clinical pharmacology. ๐Ÿ’Š๐Ÿ“š

 

 

Academic Positions ๐Ÿฅ

Mr. Chang Wang currently serves as the Pharmacist In-Charge at the Department of Pharmacy in the Second Hospital & Clinical Medical School, Lanzhou University (2019-present), where he plays a key role in clinical pharmacy operations. Prior to this, he worked as a Pharmacist at the Department of Pharmacy, 940 Hospital, Joint Service Support Force of the Chinese People’s Liberation Army (2015-2018). His extensive experience in both academic and military healthcare settings has strengthened his expertise in pharmacology, therapeutic drug monitoring, and clinical pharmacy practice. ๐Ÿ’‰๐Ÿ’Š

 

 

Research Focus

Mr. Chang Wangโ€™s research primarily revolves around pharmacology, drug monitoring, and pharmacokinetics. His work includes developing advanced analytical methods, such as UPLCโ€“MS/MS for quantifying drugs like polymyxins and caspofungin for therapeutic drug monitoring. He has contributed significantly to understanding the regulation mechanisms of drug-metabolizing enzymes and transporters, especially in hypoxia and high-altitude environments. His studies also explore the impact of intestinal microflora on drug metabolism, renal excretion, and drug efficacy under varying physiological conditions. Mr. Wang’s research is pivotal in advancing personalized medicine and drug therapy. ๐Ÿ’‰๐Ÿงฌ

 

 

Publication Top Notes

  • Development and validation of a UPLCโ€“MS/MS method for simultaneous quantification of polymyxins and caspofungin in human plasma for therapeutic drug monitoringWu, T., Pu, L., Liu, W., Wang, C., Qiu, W. (2025) ๐Ÿ“…
  • Modulation of drug-metabolizing enzymes and transporters under hypoxia environmentMin, Q., Feng, S.-L., Lu, H., Wang, R., Zhang, J.-H., Wang, C. (2019) – Cited by 3 ๐Ÿ“–
  • Effects of intestinal microflora on drug metabolismChen, Y.-Y., Wang, R., Zhang, J.-H., Wang, C., Sun, Y.-M. (2019) – Cited by 5 ๐Ÿ’Š
  • Potential regulation mechanisms of P-gp in the blood-brain barrier in hypoxiaDing, Y., Wang, R., Zhang, J., Wang, C., Yuan, X. (2019) – Cited by 15 ๐Ÿง 
  • Plasma proteomic study of acute mountain sickness susceptible and resistant individualsLu, H., Wang, R., Li, W., Sun, Y., Jia, Z. (2018) – Cited by 19 โ›ฐ๏ธ
  • Research progress of long chain non-coding RNA H19 in anoxic environment mechanismYue, X., Wang, R., Li, W., Lu, H., Zhang, J. (2018) – Cited by 1 ๐Ÿงฌ
  • Interaction of amoxicillin and nifedipine mediated by intestinal floraZhang, J.-H., Zhang, J.-M., Wang, R., Zhao, A.-P., Jia, Z.-P. (2018) – Cited by 5 ๐Ÿ’Š
  • Research progress on clinical gene polymorphism of clopidogrel resistanceSun, Y.-M., Cui, M.-X., Li, W.-B., Wang, C., Wang, R. (2018) – Cited by 3 ๐Ÿงฌ
  • Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 mLuo, B., Li, J., Yang, T., Zhao, A., Wang, R. (2018) – Cited by 11 ๐ŸŒ„
  • Advances of studies on effect of drug transporter under hypoxiaZhang, M.-X., Wang, R., Xu, W.-B., Liu, J.-J., Jia, Z.-P. (2018) – Cited by 5 ๐Ÿ’‰